ALECENSA (Genentech, Inc.)


Welcome to the PulseAid listing for the ALECENSA drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: ALECTINIB HYDROCHLORIDE
SUBSTANCE NAME: ALECTINIB HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-12-11
END MARKETING DATE: 0000-00-00


ALECENSA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionALECENSA from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2015-12-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50242-130_eb026d61-79db-448a-b33b-6ff954fe7cc5
PRODUCT NDC: 50242-130
APPLICATION NUMBER: NDA208434

Other ALECTINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.ALECENSA